TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17538165

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus capecitabine (GemCap) - oral capecitabine 650 mg/m2 twice daily on days 1 to 14 plus Gem 1,000 mg/m2 by 30‐minute infusion on days 1 and 8 every 3 weeks
Number of subjects: 319

Group type: COMPARATOR
Intervention: Gemcitabine (Gem) - 1,000 mg/m2 by 30‐minute infusion weekly for 7 weeks, followed by a 1‐week break, and then weekly for 3 weeks every 4 weeks
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus capecitabine (GemCap) in patients with good Karnofsky performance score (KPS)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Gemcitabine (Gem) in patients with good Karnofsky performance score (KPS)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Both GemCap and Gem
Number of subjects: 319
Study: 16566943

Group type: EXPERIMENTAL
Intervention: Pulse low doses of methylprednisolone (250 mg given twice IV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 14527736

Group type: EXPERIMENTAL
Intervention: Second-generation antihistamines with combined topical corticosteroid treatment (Group 1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Second-generation antihistamines without steroid treatment (Group 2)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Second-generation antihistamines (both groups)
Number of subjects: 32
Study: 10790990

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Stimulants (MPH, DEX, pemoline)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Tricyclic antidepressants (desipramine, imipramine)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Combination therapies (stimulant or nondrug intervention)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Antidepressants
Number of subjects: 78

Group type: COMPARATOR
Intervention: Stimulants vs. placebo
Number of subjects: 78

Group type: COMPARATOR
Intervention: Adverse effects of drug therapy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Long-term therapy (> or = 12 weeks)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Academic performance with stimulants
Number of subjects: 78
Study: 8932964

Group type: EXPERIMENTAL
Intervention: Standard antidepressants (imipramine, fluoxetine, sertraline)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1989742

Group type: EXPERIMENTAL
Intervention: Local anaesthesia combined with light sedation (midazolam 0.1 mg.kg‐1 and alfentanil 0 micrograms.kg‐1)
Number of subjects: 28

Group type: COMPARATOR
Intervention: General anaesthesia (propofol 2.5 mg.kg‐1, then 9 mg.kg‐1.hr‐1 and alfentanil 30 micrograms.kg‐1, then 15 micrograms.kg‐1)
Number of subjects: 28
Study: 6307340

Group type: EXPERIMENTAL
Intervention: Chymoral with Polyglycolic acid sutures
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo with Polyglycolic acid sutures
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Chymoral with catgut sutures
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo with catgut sutures
Number of subjects: 190
Study: 31313021

Group type: EXPERIMENTAL
Intervention: CPAP (N = 18)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise (N = 21)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 39
Study: 28777246

Group type: EXPERIMENTAL
Intervention: Jaw clenching
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Jaw clenching with mouthpiece
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no jaw clenching)
Number of subjects: 36
Study: 26975187

Group type: EXPERIMENTAL
Intervention: Task shifting interventions delivered by trained frontline health workers (Anganwadi workers and ASHA workers) for a minimum period of 18 months.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (standard care or no intervention).
Number of subjects: 120
Study: 25560571

Group type: EXPERIMENTAL
Intervention: Vildagliptin 100mg plus metformin
Number of subjects: 61

Group type: COMPARATOR
Intervention: Metformin monotherapy
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Vildagliptin plus metformin
Number of subjects: 61
Study: 23842505

Group type: EXPERIMENTAL
Intervention: CR® neuromodulation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 0
Study: 20863217

Group type: EXPERIMENTAL
Intervention: L-Carnitine 1000 mg/day for 12 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 18195111

Group type: EXPERIMENTAL
Intervention: ABCC2 inhibitor probenecid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonspecific inhibitor verapamil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABCB1 inhibitor valspodar (PSC833)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Talinolol
Number of subjects: 0
Study: 15928933

Group type: EXPERIMENTAL
Intervention: Active recovery (cycling at VO2peak for 5 min) in the upright position
Number of subjects: 7

Group type: COMPARATOR
Intervention: Inactive recovery (complete rest for 5 min) in the upright position
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Active recovery (cycling at VO2peak for 5 min) in the supine position
Number of subjects: 7

Group type: COMPARATOR
Intervention: Inactive recovery (complete rest for 5 min) in the supine position
Number of subjects: 7
Study: 12571548

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment for 1 week
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo-CPAP (CPAP administered at ineffective pressure)
Number of subjects: 39
Study: 10596415

Group type: EXPERIMENTAL
Intervention: Bifidobacteria (Töpfer Bifidus) administered via nasogastral tube, initial dosage of 3 times daily 1.25 x 10(8) bifidobacteria on day 2, then 6 times daily 1.25 x 10(8) bifidobacteria on day 3 until day 21
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no bifidobacteria)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bifidobacteria (Töpfer Bifidus)
Number of subjects: 100
Study: 8739869

Group type: EXPERIMENTAL
Intervention: Surgicel Nu‐knit
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vasolene gauze
Number of subjects: 60

Group type: COMPARATOR
Intervention: Merocel
Number of subjects: 60
Study: 1915209

Group type: EXPERIMENTAL
Intervention: Caffeine (3.3 mg/kg, equivalent to 2 to 3 cups of coffee)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 7046758

Group type: EXPERIMENTAL
Intervention: Tiopronin, 1 gm/day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tiopronin, 1.5 gm/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tiopronin
Number of subjects: 80
Study: 31479383

Group type: EXPERIMENTAL
Intervention: Auditory‐motor integration (AMI) intervention
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phonological memory and planning (PMP) intervention
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (CTL) intervention
Number of subjects: 12
Study: 28196063

Group type: EXPERIMENTAL
Intervention: dCRT (cisplatin 60 mg/m² on day 1 and capecitabine 625 mg/m² bd on days 1-21 for four cycles)
Number of subjects: 258

Group type: COMPARATOR
Intervention: dCRT+C (dCRT plus cetuximab 400 mg/m² on day 1 then 250 mg/m² weekly)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: dCRT
Number of subjects: 258

Group type: COMPARATOR
Intervention: dCRT+C
Number of subjects: 258
Study: 26398851

Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg for 8 weeks
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 24230931

Group type: EXPERIMENTAL
Intervention: Learning potential assessment for children with specific language impairment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Learning potential assessment for children with typical development
Number of subjects: 64
Study: 21327797

Group type: EXPERIMENTAL
Intervention: HMB (3 g/day)
Number of subjects: 28
Study: 19743466

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) 1,500mg daily
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 17942025

Group type: EXPERIMENTAL
Intervention: 50% isopropyl myristate (IPM) rinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive control (RID; pyrethrin 0.33%, piperonyl butoxide 4%)
Number of subjects: 0
Study: 12612146

Group type: EXPERIMENTAL
Intervention: Daily supplement (272 mg vitamin C, 31 mg all‐rac‐alpha‐tocopherol, and 400 micro g folic acid) for 90 days
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo for 90 days
Number of subjects: 77
Study: 11118067

Group type: EXPERIMENTAL
Intervention: Ritonavir
Number of subjects: 1251

Group type: COMPARATOR
Intervention: Indinavir
Number of subjects: 1251
Study: 9167147

Group type: EXPERIMENTAL
Intervention: Systemic gentamicin/metronidazole with gentamicin-collagen sponge (Group I)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Systemic gentamicin/metronidazole without gentamicin-collagen sponge (Group II)
Number of subjects: 221
Study: 1556292

Group type: EXPERIMENTAL
Intervention: Religious Cognitive-Behavioral Therapy (RCT)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Nonreligious Cognitive-Behavioral Therapy (NRCT)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Pastoral Counseling Treatment-as-Usual (PCT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Waiting-List Control (WLC)
Number of subjects: 59
Study: 3889361

Group type: EXPERIMENTAL
Intervention: Duplex sonography
Number of subjects: 229
Study: 31362785

Group type: EXPERIMENTAL
Intervention: Local ice cryotherapy (30 min applied twice during 1 day at an 8-h interval)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Cold CO2 (2 min applied twice during 1 day at an 8-h interval)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Ice-treated knees (phase II)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Contralateral non-treated arthritic knees (phase II)
Number of subjects: 47
Study: 28228420

Group type: EXPERIMENTAL
Intervention: 25% Calorie Restriction (CR, n = 143)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Ad libitum control (AL, n = 75)
Number of subjects: 218
Study: 25885180

Group type: EXPERIMENTAL
Intervention: Cool dialysate at 35.5°C
Number of subjects: 20

Group type: COMPARATOR
Intervention: Warm dialysate at 37°C
Number of subjects: 20
Study: 24088417

Group type: EXPERIMENTAL
Intervention: Active implementation of a disease management programme (DMP) for COPD
Number of subjects: 744

Group type: COMPARATOR
Intervention: Usual implementation strategy (Control group)
Number of subjects: 744

Group type: COMPARATOR
Intervention: External control group
Number of subjects: 744
Study: 21418180

Group type: EXPERIMENTAL
Intervention: A‐PC
Number of subjects: 201

Group type: COMPARATOR
Intervention: C‐PC
Number of subjects: 201
Study: 19638799

Group type: EXPERIMENTAL
Intervention: Telemedicine (TM) with wound care specialist (WCS) consults (Group A)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Weekly visits with WCSs (Group B)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual and customary care (Group C)
Number of subjects: 103
Study: 16978805

Group type: EXPERIMENTAL
Intervention: Formula with prebiotic fructo-oligosaccharides at a concentration of 0.4 g/dL
Number of subjects: 56

Group type: COMPARATOR
Intervention: Formula with maltodextrin as a placebo
Number of subjects: 56
Study: 15547636

Group type: EXPERIMENTAL
Intervention: PRO‐SELF Pain Control Program
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 174
Study: 11384825

Group type: EXPERIMENTAL
Intervention: Tailored print booklets plus telephone counseling (TP+TC)
Number of subjects: 1127

Group type: COMPARATOR
Intervention: Tailored print booklets (TP)
Number of subjects: 1127

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 1127
Study: 10210340

Group type: EXPERIMENTAL
Intervention: HAIC using fixed catheter‐tip method
Number of subjects: 90

Group type: COMPARATOR
Intervention: HAIC using conventional method
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: HAIC without prior TACE
Number of subjects: 90

Group type: COMPARATOR
Intervention: HAIC with prior TACE
Number of subjects: 90
Study: 7843445

Group type: EXPERIMENTAL
Intervention: Air bubbles loaded into the transfer catheter (group I)
Number of subjects: 196

Group type: COMPARATOR
Intervention: No air bubbles used (group II)
Number of subjects: 196
Study: 2205292

Group type: EXPERIMENTAL
Intervention: Vitamin-mineral supplement daily for 28 days
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo daily for 28 days
Number of subjects: 227
Study: 152694

Group type: EXPERIMENTAL
Intervention: 6.25% aluminum chloride hexahydrate in anhydrous ethanol (ACAE)
Number of subjects: 141
Study: 31305150

Group type: EXPERIMENTAL
Intervention: Modified course
Number of subjects: 226

Group type: COMPARATOR
Intervention: Traditional course
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Both courses
Number of subjects: 226
Study: 29127858

Group type: EXPERIMENTAL
Intervention: Telephonic review (FT)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Face-to-face clinic management (FC)
Number of subjects: 429
Study: 26141142

Group type: EXPERIMENTAL
Intervention: Switch to antipsychotic monotherapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Stay on polypharmacy
Number of subjects: 104
Study: 23892681

Group type: EXPERIMENTAL
Intervention: Fortified maize meal (soy protein, iron, vitamin A, folic acid, zinc, niacin)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Unfortified flour
Number of subjects: 308
Study: 21612469

Group type: EXPERIMENTAL
Intervention: Dust-mite allergen
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Albuterol followed by methacholine (control)
Number of subjects: 48
Study: 19529912

Group type: EXPERIMENTAL
Intervention: Unguided self‐advancing jejunal tube (Tiger Tube)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Endoscopic guided jejunal tube (Freka Trelumina)
Number of subjects: 42
Study: 16722829

Group type: EXPERIMENTAL
Intervention: 30 mg primaquine with food
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 30 mg primaquine with grapefruit juice
Number of subjects: 20

Group type: COMPARATOR
Intervention: 30 mg primaquine in fasting state
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison between genders
Number of subjects: 20
Study: 12790260

Group type: EXPERIMENTAL
Intervention: 8-week group intervention
Number of subjects: 73

Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 73
Study: 10375047

Group type: EXPERIMENTAL
Intervention: Anthropometric measures (BMI, waist girth, WHR, sum of three skinfolds) among urban and rural boys and girls.
Number of subjects: 5518

Group type: EXPERIMENTAL
Intervention: Anthropometric measures among boys across SES tertiles.
Number of subjects: 5518

Group type: EXPERIMENTAL
Intervention: Anthropometric measures among girls across SES tertiles.
Number of subjects: 5518

Group type: EXPERIMENTAL
Intervention: Statistical interactions between school year and body fatness.
Number of subjects: 5518
Study: 8686522

Group type: EXPERIMENTAL
Intervention: 5.0 mg morphine and 2.5 mg dehydrobenzperidol (DHB) in 10 ml physiological saline
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 5.0 mg morphine and 0.1 mg fentanyl in 10 ml physiological saline
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo group with saline only
Number of subjects: 68
Study: 1905474

Group type: EXPERIMENTAL
Intervention: Canola oil-based diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Safflower oil-based diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: Baseline diet
Number of subjects: 16
Study: 6619578

Group type: EXPERIMENTAL
Intervention: recombinant leukocyte A interferon (rIFN‐alpha A) 10 X 10(6) units per day for four days
Number of subjects: 26

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: recombinant leukocyte A interferon (rIFN‐alpha A)
Number of subjects: 26
Study: 4026908

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg once daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Metoprolol 50 mg twice daily
Number of subjects: 18
Study: 30370872

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma applied in-between temporalis fascia graft and tympanic membrane remnant during underlay myringoplasty (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine underlay tympanoplasty (n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma group (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine underlay tympanoplasty group (n = 20)
Number of subjects: 40
Study: 27857189

Group type: EXPERIMENTAL
Intervention: Repaglinide (oral administration for 8 weeks)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Repaglinide with KCNQ1 inhibitor
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Repaglinide in patients with CT or TT genotypes
Number of subjects: 82
Study: 24075865

Group type: EXPERIMENTAL
Intervention: Laparoscopic cystectomy by stripping with saline injection (saline group)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Laparoscopic cystectomy by stripping with vasopressin injection technique (VIT group)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Laparoscopic cystectomy by stripping without injection (control group)
Number of subjects: 86
Study: 22277625

Group type: EXPERIMENTAL
Intervention: Educational programme consisting of three group educational sessions followed by one individual educational session.
Number of subjects: 141

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 141
Study: 20113339

Group type: EXPERIMENTAL
Intervention: Pregabalin 150-600 mg/day (dosed twice daily)
Number of subjects: 476
Study: 18377153

Group type: EXPERIMENTAL
Intervention: Mediterranean Lifestyle Program (MLP)
Number of subjects: 0
Study: 16271654

Group type: EXPERIMENTAL
Intervention: Telephone psychotherapy program (TPP) consisting of 8-12 telephone sessions (8 core CBT sessions and 3-4 clinical booster sessions) delivered by a master-level therapist.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telephone psychotherapy program (TPP) during maintenance-phase treatment (6-12 months).
Number of subjects: 0
Study: 12499212

Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir 400/100 mg BID
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir 533/133 mg BID
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: lopinavir and efavirenz IQ parameters
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: baseline characteristics
Number of subjects: 57
Study: 10204899

Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 110

Group type: COMPARATOR
Intervention: 0.125% ropivacaine
Number of subjects: 110

Group type: COMPARATOR
Intervention: saline
Number of subjects: 110
Study: 8888300

Group type: EXPERIMENTAL
Intervention: Caucasian observers discriminating male and female Caucasian faces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oriental observers discriminating male and female Japanese faces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female observers of both races
Number of subjects: 0
Study: 1794268

Group type: EXPERIMENTAL
Intervention: Gliclazide
Number of subjects: 584

Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 584

Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 584
Study: 6575987

Group type: EXPERIMENTAL
Intervention: Amine fluoride dentifrice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monofluorophosphate-sodium fluoride dentifrice
Number of subjects: 0
Study: 30464128

Group type: EXPERIMENTAL
Intervention: Combined thrombus burden reduction therapy
Number of subjects: 46
Study: 30248056

Group type: EXPERIMENTAL
Intervention: Personalized neurofeedback cognitive training using the BRAINMEM system, comprising 24 sessions over eight weeks and three monthly booster sessions.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist-Control group (no specific intervention details provided).
Number of subjects: 0
Study: 27940785

Group type: EXPERIMENTAL
Intervention: School-located influenza vaccination (SLIV) clinics
Number of subjects: 19776

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 19776

Group type: EXPERIMENTAL
Intervention: School-located influenza vaccination (SLIV) clinics in suburban schools
Number of subjects: 19776

Group type: COMPARATOR
Intervention: Usual care (control) in suburban schools
Number of subjects: 19776

Group type: EXPERIMENTAL
Intervention: School-located influenza vaccination (SLIV) clinics in urban schools
Number of subjects: 19776

Group type: COMPARATOR
Intervention: Usual care (control) in urban schools
Number of subjects: 19776
Study: 24445833

Group type: EXPERIMENTAL
Intervention: Inactivated quadrivalent influenza vaccine (QIV)
Number of subjects: 4363

Group type: COMPARATOR
Intervention: Inactivated control trivalent influenza vaccines (TIVs) containing Victoria-lineage B strain
Number of subjects: 4363

Group type: COMPARATOR
Intervention: Inactivated control trivalent influenza vaccines (TIVs) containing Yamagata-lineage B strain
Number of subjects: 4363
Study: 21916952

Group type: EXPERIMENTAL
Intervention: Mandibular overdenture retained by two splinted implants with bar-clip system
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional dentures (CDs)
Number of subjects: 29
Study: 20082624

Group type: COMPARATOR
Intervention: Glipizide controlled-release (CR) tablets monotherapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Glipizide controlled-release (CR) tablets plus acarbose
Number of subjects: 40
Study: 18392503

Group type: EXPERIMENTAL
Intervention: Mouthwash with oxygenating and antimicrobial substances
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 50
Study: 15801331

Group type: EXPERIMENTAL
Intervention: LY333013
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50